New Results
Using genetic drug-target networks to develop new drug hypotheses for major depressive disorder
View ORCID ProfileHéléna A Gaspar, Zachary Gerring, View ORCID ProfileChristopher Hübel, View ORCID ProfileChristel M Middeldorp, View ORCID ProfileEske M Derks, View ORCID ProfileGerome Breen
doi: https://doi.org/10.1101/304113
Héléna A Gaspar
1King’s College London; Institute of Psychiatry, Psychology and Neuroscience; MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre; UK
2National Institute for Health Research Biomedical Research Centre; South London and Maudsley National Health Service Trust; UK
PhDZachary Gerring
3Translational Neurogenomics Laboratory; QIMR Berghofer Institute of Medical Research; Australia
PhDChristopher Hübel
1King’s College London; Institute of Psychiatry, Psychology and Neuroscience; MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre; UK
2National Institute for Health Research Biomedical Research Centre; South London and Maudsley National Health Service Trust; UK
4Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm
MD MSc, Major Depressive Disorder Working Group of the Psychiatric Genomics ConsortiumChristel M Middeldorp
5Child Health Research Centre; University of Queensland; Australia
6Child and Youth Mental Health Service; Children’s Health Queensland Hospital and Health Service; Australia
7Biological Psychology, Vrije Universiteit Amsterdam; the Netherlands
MD PhDEske M Derks
3Translational Neurogenomics Laboratory; QIMR Berghofer Institute of Medical Research; Australia
PhDGerome Breen
1King’s College London; Institute of Psychiatry, Psychology and Neuroscience; MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre; UK
2National Institute for Health Research Biomedical Research Centre; South London and Maudsley National Health Service Trust; UK
PhDArticle usage
Posted April 18, 2018.
Using genetic drug-target networks to develop new drug hypotheses for major depressive disorder
Héléna A Gaspar, Zachary Gerring, Christopher Hübel, Christel M Middeldorp, Eske M Derks, Gerome Breen
bioRxiv 304113; doi: https://doi.org/10.1101/304113
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)